FDA 483 - iRhythm Technologies Inc - July 31, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
iRhythm Technologies Inc. in San Francisco was inspected regarding its medical device manufacturing. The inspection revealed significant deficiencies in corrective and preventive action procedures, inadequate risk analysis for its cardiac monitoring devices, and a failure to submit required Medical Device Reports (MDRs) for malfunctions involving both CCT personnel misreads and algorithm errors. These issues indicate a systemic problem in identifying, investigating, and reporting quality problems that could lead to serious patient harm.
ID · ad37cc26-32dc-4534-86e3-30dc55f7191d